The Zhitong Finance App learned that on Tuesday, TEVA.US (TEVA.US) rose more than 4% to 42.65 US dollars, and its stock price reached a record high. According to the news, Teva Pharmaceuticals announced financial results for the third quarter of 2026. The company's non-GAAP earnings per share were 0.86 US dollars, exceeding market expectations of 0.14 US dollars; revenue was 4.4 billion US dollars, down 2% year on year, exceeding market expectations of 170 million US dollars.

Zhitongcaijing · 4d ago
The Zhitong Finance App learned that on Tuesday, TEVA.US (TEVA.US) rose more than 4% to 42.65 US dollars, and its stock price reached a record high. According to the news, Teva Pharmaceuticals announced financial results for the third quarter of 2026. The company's non-GAAP earnings per share were 0.86 US dollars, exceeding market expectations of 0.14 US dollars; revenue was 4.4 billion US dollars, down 2% year on year, exceeding market expectations of 170 million US dollars.